SubmitCancel

Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.

P27361

- MK03_HUMAN

UniProt

P27361 - MK03_HUMAN

(max 400 entries)x

Your basket is currently empty.

Select item(s) and click on "Add to basket" to create your own collection here
(400 entries max)

Protein
Mitogen-activated protein kinase 3
Gene
MAPK3, ERK1, PRKM3
Organism
Homo sapiens (Human)
Status
Reviewed - Annotation score: 5 out of 5 - Experimental evidence at protein leveli

Functioni

Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, cytoskeletal rearrangements. The MAPK/ERK cascade plays also a role in initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors. About 160 substrates have already been discovered for ERKs. Many of these substrates are localized in the nucleus, and seem to participate in the regulation of transcription upon stimulation. However, other substrates are found in the cytosol as well as in other cellular organelles, and those are responsible for processes such as translation, mitosis and apoptosis. Moreover, the MAPK/ERK cascade is also involved in the regulation of the endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC); as well as in the fragmentation of the Golgi apparatus during mitosis. The substrates include transcription factors (such as ATF2, BCL6, ELK1, ERF, FOS, HSF4 or SPZ1), cytoskeletal elements (such as CANX, CTTN, GJA1, MAP2, MAPT, PXN, SORBS3 or STMN1), regulators of apoptosis (such as BAD, BTG2, CASP9, DAPK1, IER3, MCL1 or PPARG), regulators of translation (such as EIF4EBP1) and a variety of other signaling-related molecules (like ARHGEF2, FRS2 or GRB10). Protein kinases (such as RAF1, RPS6KA1/RSK1, RPS6KA3/RSK2, RPS6KA2/RSK3, RPS6KA6/RSK4, SYK, MKNK1/MNK1, MKNK2/MNK2, RPS6KA5/MSK1, RPS6KA4/MSK2, MAPKAPK3 or MAPKAPK5) and phosphatases (such as DUSP1, DUSP4, DUSP6 or DUSP16) are other substrates which enable the propagation the MAPK/ERK signal to additional cytosolic and nuclear targets, thereby extending the specificity of the cascade.12 Publications

Catalytic activityi

ATP + a protein = ADP + a phosphoprotein.

Cofactori

Magnesium By similarity.

Enzyme regulationi

Phosphorylated by MAP2K1/MEK1 and MAP2K2/MEK2 on Thr-202 and Tyr-204 in response to external stimuli like insulin or NGF. Both phosphorylations are required for activity. This phosphorylation causes dramatic conformational changes, which enable full activation and interaction of MAPK1/ERK2 with its substrates. Dephosphorylated and inactivated by DUSP3, DUSP6 and DUSP9.2 Publications

Sites

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Binding sitei71 – 711ATP By similarity
Active sitei166 – 1661Proton acceptor By similarity

Regions

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Nucleotide bindingi48 – 569ATP By similarity

GO - Molecular functioni

  1. ATP binding Source: UniProtKB-KW
  2. MAP kinase activity Source: UniProtKB
  3. phosphatase binding Source: UniProtKB
  4. protein binding Source: UniProtKB

GO - Biological processi

  1. BMP signaling pathway Source: BHF-UCL
  2. DNA damage induced protein phosphorylation Source: UniProtKB
  3. Fc-epsilon receptor signaling pathway Source: Reactome
  4. Fc-gamma receptor signaling pathway involved in phagocytosis Source: Reactome
  5. JAK-STAT cascade involved in growth hormone signaling pathway Source: Reactome
  6. MAPK cascade Source: BHF-UCL
  7. MyD88-dependent toll-like receptor signaling pathway Source: Reactome
  8. MyD88-independent toll-like receptor signaling pathway Source: Reactome
  9. Ras protein signal transduction Source: Reactome
  10. TRIF-dependent toll-like receptor signaling pathway Source: Reactome
  11. activation of MAPK activity Source: Reactome
  12. activation of MAPKK activity Source: Reactome
  13. apoptotic process Source: UniProtKB-KW
  14. axon guidance Source: Reactome
  15. blood coagulation Source: Reactome
  16. cartilage development Source: Ensembl
  17. caveolin-mediated endocytosis Source: UniProtKB
  18. cell cycle Source: UniProtKB-KW
  19. cellular response to mechanical stimulus Source: UniProtKB
  20. cytokine-mediated signaling pathway Source: Reactome
  21. epidermal growth factor receptor signaling pathway Source: Reactome
  22. fibroblast growth factor receptor signaling pathway Source: Reactome
  23. gene expression Source: Reactome
  24. innate immune response Source: Reactome
  25. insulin receptor signaling pathway Source: Reactome
  26. interleukin-1-mediated signaling pathway Source: BHF-UCL
  27. lipopolysaccharide-mediated signaling pathway Source: Ensembl
  28. negative regulation of apolipoprotein binding Source: Ensembl
  29. neurotrophin TRK receptor signaling pathway Source: Reactome
  30. organ morphogenesis Source: Ensembl
  31. peptidyl-tyrosine autophosphorylation Source: UniProtKB
  32. phosphorylation Source: UniProtKB
  33. platelet activation Source: Reactome
  34. positive regulation of ERK1 and ERK2 cascade Source: BHF-UCL
  35. positive regulation of histone acetylation Source: BHF-UCL
  36. positive regulation of histone phosphorylation Source: BHF-UCL
  37. positive regulation of protein phosphorylation Source: BHF-UCL
  38. positive regulation of transcription from RNA polymerase II promoter Source: BHF-UCL
  39. protein phosphorylation Source: UniProtKB
  40. regulation of Golgi inheritance Source: UniProtKB
  41. regulation of cytoskeleton organization Source: UniProtKB
  42. regulation of early endosome to late endosome transport Source: UniProtKB
  43. regulation of sequence-specific DNA binding transcription factor activity Source: Reactome
  44. regulation of stress-activated MAPK cascade Source: UniProtKB
  45. response to epidermal growth factor Source: UniProtKB
  46. response to exogenous dsRNA Source: Ensembl
  47. sensory perception of pain Source: Ensembl
  48. small GTPase mediated signal transduction Source: Reactome
  49. stress-activated MAPK cascade Source: Reactome
  50. toll-like receptor 10 signaling pathway Source: Reactome
  51. toll-like receptor 2 signaling pathway Source: Reactome
  52. toll-like receptor 3 signaling pathway Source: Reactome
  53. toll-like receptor 4 signaling pathway Source: Reactome
  54. toll-like receptor 5 signaling pathway Source: Reactome
  55. toll-like receptor 9 signaling pathway Source: Reactome
  56. toll-like receptor TLR1:TLR2 signaling pathway Source: Reactome
  57. toll-like receptor TLR6:TLR2 signaling pathway Source: Reactome
  58. toll-like receptor signaling pathway Source: Reactome
  59. transcription from RNA polymerase I promoter Source: Reactome
  60. transcription initiation from RNA polymerase I promoter Source: Reactome
  61. viral process Source: UniProtKB-KW
Complete GO annotation...

Keywords - Molecular functioni

Kinase, Serine/threonine-protein kinase, Transferase

Keywords - Biological processi

Apoptosis, Cell cycle, Host-virus interaction

Keywords - Ligandi

ATP-binding, Nucleotide-binding

Enzyme and pathway databases

BRENDAi2.7.11.24. 2681.
ReactomeiREACT_1100. Golgi Cisternae Pericentriolar Stack Reorganization.
REACT_111133. Growth hormone receptor signaling.
REACT_111184. Negative regulation of FGFR signaling.
REACT_115831. ISG15 antiviral mechanism.
REACT_120966. Gastrin-CREB signalling pathway via PKC and MAPK.
REACT_12436. ERKs are inactivated.
REACT_12599. ERK/MAPK targets.
REACT_1391. ERK1 activation.
REACT_160086. Regulation of actin dynamics for phagocytic cup formation.
REACT_163701. FCERI mediated MAPK activation.
REACT_169168. Senescence-Associated Secretory Phenotype (SASP).
REACT_169325. Oncogene Induced Senescence.
REACT_169436. Oxidative Stress Induced Senescence.
REACT_18334. NCAM signaling for neurite out-growth.
REACT_200780. Regulation of HSF1-mediated heat shock response.
REACT_21326. Activation of the AP-1 family of transcription factors.
REACT_21384. Thrombin signalling through proteinase activated receptors (PARs).
REACT_22272. Signal transduction by L1.
REACT_2232. RNA Polymerase I Promoter Opening.
REACT_25195. Advanced glycosylation endproduct receptor signaling.
REACT_508. Signal attenuation.
REACT_9470. Signaling by FGFR.
SignaLinkiP27361.

Names & Taxonomyi

Protein namesi
Recommended name:
Mitogen-activated protein kinase 3 (EC:2.7.11.24)
Short name:
MAP kinase 3
Short name:
MAPK 3
Alternative name(s):
ERT2
Extracellular signal-regulated kinase 1
Short name:
ERK-1
Insulin-stimulated MAP2 kinase
MAP kinase isoform p44
Short name:
p44-MAPK
Microtubule-associated protein 2 kinase
p44-ERK1
Gene namesi
Name:MAPK3
Synonyms:ERK1, PRKM3
OrganismiHomo sapiens (Human)
Taxonomic identifieri9606 [NCBI]
Taxonomic lineageiEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo
ProteomesiUP000005640: Chromosome 16

Organism-specific databases

HGNCiHGNC:6877. MAPK3.

Subcellular locationi

Cytoplasm. Nucleus
Note: Autophosphorylation at Thr-207 promotes nuclear localization.2 Publications

GO - Cellular componenti

  1. Golgi apparatus Source: UniProtKB
  2. caveola Source: UniProtKB
  3. cytoskeleton Source: UniProtKB
  4. cytosol Source: UniProtKB
  5. early endosome Source: UniProtKB
  6. extracellular vesicular exosome Source: UniProt
  7. focal adhesion Source: UniProtKB
  8. late endosome Source: UniProtKB
  9. microtubule cytoskeleton Source: HPA
  10. mitochondrion Source: UniProtKB
  11. nucleoplasm Source: Reactome
  12. nucleus Source: UniProtKB
  13. pseudopodium Source: Ensembl
Complete GO annotation...

Keywords - Cellular componenti

Cytoplasm, Nucleus

Pathology & Biotechi

Organism-specific databases

PharmGKBiPA30622.

PTM / Processingi

Molecule processing

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Initiator methioninei1 – 11Removed1 Publication
Chaini2 – 379378Mitogen-activated protein kinase 3
PRO_0000186251Add
BLAST

Amino acid modifications

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Modified residuei2 – 21N-acetylalanine4 Publications
Modified residuei170 – 1701Phosphoserine
Modified residuei198 – 1981Phosphothreonine1 Publication
Modified residuei202 – 2021Phosphothreonine; by MAP2K1 and MAP2K23 Publications
Modified residuei204 – 2041Phosphotyrosine; by MAP2K1 and MAP2K25 Publications
Modified residuei207 – 2071Phosphothreonine; by autocatalysis1 Publication

Post-translational modificationi

Phosphorylated upon KIT and FLT3 signaling By similarity. Dually phosphorylated on Thr-202 and Tyr-204, which activates the enzyme. Ligand-activated ALK induces tyrosine phosphorylation. Dephosphorylated by PTPRJ at Tyr-204.6 Publications

Keywords - PTMi

Acetylation, Phosphoprotein

Proteomic databases

MaxQBiP27361.
PaxDbiP27361.
PRIDEiP27361.

PTM databases

PhosphoSiteiP27361.

Expressioni

Gene expression databases

ArrayExpressiP27361.
BgeeiP27361.
CleanExiHS_MAPK3.
GenevestigatoriP27361.

Organism-specific databases

HPAiCAB002683.
HPA003995.
HPA005700.

Interactioni

Subunit structurei

Binds both upstream activators and downstream substrates in multimolecular complexes. Found in a complex with at least BRAF, HRAS, MAP2K1/MEK1, MAPK3 and RGS14 By similarity. Binds to HIV-1 Nef through its SH3 domain. This interaction inhibits its tyrosine-kinase activity. Interacts with ADAM15, ARRB2, CANX, DAPK1 (via death domain), HSF4, IER3, MAP2K1/MEK1, MORG1, NISCH, and SGK1. Interacts with PEA15 and MKNK2 By similarity. MKNK2 isoform 1 binding prevents from dephosphorylation and inactivation By similarity. Interacts with TPR.12 Publications

Binary interactionsi

WithEntry#Exp.IntActNotes
DAPK1P533554EBI-73995,EBI-358616
DUSP1P285624EBI-73995,EBI-975493
MAP2K1Q027502EBI-73995,EBI-492564
MAPK1P284823EBI-73995,EBI-959949
MAPK14Q165395EBI-73995,EBI-73946
NsmfQ9EPI62EBI-73995,EBI-6899705From a different organism.
PTPRBP234672EBI-73995,EBI-1265766
PTPRJQ129135EBI-73995,EBI-2264500
PtprrQ621323EBI-73995,EBI-6954051From a different organism.
SCRIBQ141602EBI-73995,EBI-357345

Protein-protein interaction databases

BioGridi111581. 114 interactions.
DIPiDIP-30985N.
IntActiP27361. 50 interactions.
MINTiMINT-99599.
STRINGi9606.ENSP00000263025.

Structurei

Secondary structure

Legend: HelixTurnBeta strand
Show more details
Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Turni39 – 413
Beta strandi42 – 498
Beta strandi55 – 617
Turni62 – 654
Beta strandi66 – 738
Helixi79 – 9416
Beta strandi104 – 1074
Turni112 – 1143
Beta strandi118 – 1236
Beta strandi126 – 1283
Helixi129 – 1357
Helixi140 – 15920
Beta strandi171 – 1744
Beta strandi180 – 1823
Helixi193 – 1953
Helixi208 – 2103
Helixi214 – 2174
Helixi225 – 24016
Helixi252 – 26110
Turni266 – 2683
Helixi275 – 2839
Helixi292 – 2954
Helixi301 – 31010
Turni315 – 3173
Helixi321 – 3255
Helixi328 – 3303
Turni331 – 3333
Helixi336 – 3383
Helixi352 – 3543
Helixi357 – 36711
Helixi369 – 3713

3D structure databases

Select the link destinations:
PDBe
RCSB PDB
PDBj
Links Updated
EntryMethodResolution (Å)ChainPositionsPDBsum
2ZOQX-ray2.39A/B1-379[»]
ProteinModelPortaliP27361.
SMRiP27361. Positions 24-375.

Miscellaneous databases

EvolutionaryTraceiP27361.

Family & Domainsi

Domains and Repeats

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Domaini42 – 330289Protein kinase
Add
BLAST

Motif

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Motifi202 – 2043TXY

Domaini

The TXY motif contains the threonine and tyrosine residues whose phosphorylation activates the MAP kinases.1 Publication

Sequence similaritiesi

Phylogenomic databases

eggNOGiCOG0515.
HOGENOMiHOG000233024.
HOVERGENiHBG014652.
InParanoidiP27361.
KOiK04371.
OMAiAEMLSNK.
OrthoDBiEOG7M3J0K.
PhylomeDBiP27361.
TreeFamiTF105097.

Family and domain databases

InterProiIPR011009. Kinase-like_dom.
IPR003527. MAP_kinase_CS.
IPR008349. MAPK_ERK1/2.
IPR000719. Prot_kinase_dom.
IPR017441. Protein_kinase_ATP_BS.
IPR002290. Ser/Thr_dual-sp_kinase_dom.
IPR008271. Ser/Thr_kinase_AS.
[Graphical view]
PfamiPF00069. Pkinase. 1 hit.
[Graphical view]
PRINTSiPR01770. ERK1ERK2MAPK.
SMARTiSM00220. S_TKc. 1 hit.
[Graphical view]
SUPFAMiSSF56112. SSF56112. 1 hit.
PROSITEiPS01351. MAPK. 1 hit.
PS00107. PROTEIN_KINASE_ATP. 1 hit.
PS50011. PROTEIN_KINASE_DOM. 1 hit.
PS00108. PROTEIN_KINASE_ST. 1 hit.
[Graphical view]

Sequences (3)i

Sequence statusi: Complete.

Sequence processingi: The displayed sequence is further processed into a mature form.

This entry describes 3 isoformsi produced by alternative splicing. Align

Isoform 1 (identifier: P27361-1) [UniParc]FASTAAdd to Basket

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.

« Hide

MAAAAAQGGG GGEPRRTEGV GPGVPGEVEM VKGQPFDVGP RYTQLQYIGE    50
GAYGMVSSAY DHVRKTRVAI KKISPFEHQT YCQRTLREIQ ILLRFRHENV 100
IGIRDILRAS TLEAMRDVYI VQDLMETDLY KLLKSQQLSN DHICYFLYQI 150
LRGLKYIHSA NVLHRDLKPS NLLINTTCDL KICDFGLARI ADPEHDHTGF 200
LTEYVATRWY RAPEIMLNSK GYTKSIDIWS VGCILAEMLS NRPIFPGKHY 250
LDQLNHILGI LGSPSQEDLN CIINMKARNY LQSLPSKTKV AWAKLFPKSD 300
SKALDLLDRM LTFNPNKRIT VEEALAHPYL EQYYDPTDEP VAEEPFTFAM 350
ELDDLPKERL KELIFQETAR FQPGVLEAP 379
Length:379
Mass (Da):43,136
Last modified:January 23, 2007 - v4
Checksum:iE6020CE413EC41F7
GO
Isoform 2 (identifier: P27361-2) [UniParc]FASTAAdd to Basket

The sequence of this isoform differs from the canonical sequence as follows:
     259-302: Missing.

Show »
Length:335
Mass (Da):38,275
Checksum:i54DA760A09F1F2F5
GO
Isoform 3 (identifier: P27361-3) [UniParc]FASTAAdd to Basket

Also known as: ERK1b

The sequence of this isoform differs from the canonical sequence as follows:
     340-379: PVAEEPFTFAMELDDLPKERLKELIFQETARFQPGVLEAP → VGQSPAAVGLGAGEQGGT

Show »
Length:357
Mass (Da):40,088
Checksum:iF2C6D29C623AC072
GO

Natural variant

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Natural varianti323 – 3231E → K.1 Publication
Corresponds to variant rs55859133 [ dbSNP | Ensembl ].
VAR_042253

Alternative sequence

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Alternative sequencei259 – 30244Missing in isoform 2.
VSP_041906Add
BLAST
Alternative sequencei340 – 37940PVAEE…VLEAP → VGQSPAAVGLGAGEQGGT in isoform 3.
VSP_041907Add
BLAST

Sequence conflict

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Sequence conflicti174 – 1741I → S in CAA42744. 1 Publication
Sequence conflicti174 – 1741I → S in AAK52329. 1 Publication

Sequence databases

Select the link destinations:
EMBL
GenBank
DDBJ
Links Updated
X60188 mRNA. Translation: CAA42744.1.
AY033607 mRNA. Translation: AAK52329.1.
DQ399291 mRNA. Translation: ABD60302.1.
EU332853 Genomic DNA. Translation: ABY87542.1.
AC012645 Genomic DNA. No translation available.
CH471238 Genomic DNA. Translation: EAW79912.1.
CH471238 Genomic DNA. Translation: EAW79915.1.
BC013992 mRNA. Translation: AAH13992.1.
M84490 mRNA. Translation: AAA36142.1.
Z11696 mRNA. Translation: CAA77754.1.
CCDSiCCDS10672.1. [P27361-1]
CCDS42148.1. [P27361-2]
CCDS42149.1. [P27361-3]
PIRiA48082.
RefSeqiNP_001035145.1. NM_001040056.2. [P27361-3]
NP_001103361.1. NM_001109891.1. [P27361-2]
NP_002737.2. NM_002746.2. [P27361-1]
UniGeneiHs.861.

Genome annotation databases

EnsembliENST00000263025; ENSP00000263025; ENSG00000102882. [P27361-1]
ENST00000322266; ENSP00000327293; ENSG00000102882. [P27361-2]
ENST00000395199; ENSP00000378625; ENSG00000102882. [P27361-3]
ENST00000395202; ENSP00000378628; ENSG00000102882. [P27361-2]
ENST00000403394; ENSP00000384895; ENSG00000102882. [P27361-3]
GeneIDi5595.
KEGGihsa:5595.
UCSCiuc002dwr.3. human. [P27361-1]
uc002dwt.3. human. [P27361-3]
uc002dwv.4. human. [P27361-2]

Polymorphism databases

DMDMi232066.

Keywords - Coding sequence diversityi

Alternative splicing, Polymorphism

Cross-referencesi

Web resourcesi

Atlas of Genetics and Cytogenetics in Oncology and Haematology

Sequence databases

Select the link destinations:
EMBL
GenBank
DDBJ
Links Updated
X60188 mRNA. Translation: CAA42744.1 .
AY033607 mRNA. Translation: AAK52329.1 .
DQ399291 mRNA. Translation: ABD60302.1 .
EU332853 Genomic DNA. Translation: ABY87542.1 .
AC012645 Genomic DNA. No translation available.
CH471238 Genomic DNA. Translation: EAW79912.1 .
CH471238 Genomic DNA. Translation: EAW79915.1 .
BC013992 mRNA. Translation: AAH13992.1 .
M84490 mRNA. Translation: AAA36142.1 .
Z11696 mRNA. Translation: CAA77754.1 .
CCDSi CCDS10672.1. [P27361-1 ]
CCDS42148.1. [P27361-2 ]
CCDS42149.1. [P27361-3 ]
PIRi A48082.
RefSeqi NP_001035145.1. NM_001040056.2. [P27361-3 ]
NP_001103361.1. NM_001109891.1. [P27361-2 ]
NP_002737.2. NM_002746.2. [P27361-1 ]
UniGenei Hs.861.

3D structure databases

Select the link destinations:
PDBe
RCSB PDB
PDBj
Links Updated
Entry Method Resolution (Å) Chain Positions PDBsum
2ZOQ X-ray 2.39 A/B 1-379 [» ]
ProteinModelPortali P27361.
SMRi P27361. Positions 24-375.
ModBasei Search...
MobiDBi Search...

Protein-protein interaction databases

BioGridi 111581. 114 interactions.
DIPi DIP-30985N.
IntActi P27361. 50 interactions.
MINTi MINT-99599.
STRINGi 9606.ENSP00000263025.

Chemistry

BindingDBi P27361.
ChEMBLi CHEMBL1907606.
DrugBanki DB01169. Arsenic trioxide.
DB01064. Isoproterenol.
DB00641. Simvastatin.
DB00605. Sulindac.
GuidetoPHARMACOLOGYi 1494.

PTM databases

PhosphoSitei P27361.

Polymorphism databases

DMDMi 232066.

Proteomic databases

MaxQBi P27361.
PaxDbi P27361.
PRIDEi P27361.

Protocols and materials databases

DNASUi 5595.
Structural Biology Knowledgebase Search...

Genome annotation databases

Ensembli ENST00000263025 ; ENSP00000263025 ; ENSG00000102882 . [P27361-1 ]
ENST00000322266 ; ENSP00000327293 ; ENSG00000102882 . [P27361-2 ]
ENST00000395199 ; ENSP00000378625 ; ENSG00000102882 . [P27361-3 ]
ENST00000395202 ; ENSP00000378628 ; ENSG00000102882 . [P27361-2 ]
ENST00000403394 ; ENSP00000384895 ; ENSG00000102882 . [P27361-3 ]
GeneIDi 5595.
KEGGi hsa:5595.
UCSCi uc002dwr.3. human. [P27361-1 ]
uc002dwt.3. human. [P27361-3 ]
uc002dwv.4. human. [P27361-2 ]

Organism-specific databases

CTDi 5595.
GeneCardsi GC16M030125.
HGNCi HGNC:6877. MAPK3.
HPAi CAB002683.
HPA003995.
HPA005700.
MIMi 601795. gene.
neXtProti NX_P27361.
PharmGKBi PA30622.
GenAtlasi Search...

Phylogenomic databases

eggNOGi COG0515.
HOGENOMi HOG000233024.
HOVERGENi HBG014652.
InParanoidi P27361.
KOi K04371.
OMAi AEMLSNK.
OrthoDBi EOG7M3J0K.
PhylomeDBi P27361.
TreeFami TF105097.

Enzyme and pathway databases

BRENDAi 2.7.11.24. 2681.
Reactomei REACT_1100. Golgi Cisternae Pericentriolar Stack Reorganization.
REACT_111133. Growth hormone receptor signaling.
REACT_111184. Negative regulation of FGFR signaling.
REACT_115831. ISG15 antiviral mechanism.
REACT_120966. Gastrin-CREB signalling pathway via PKC and MAPK.
REACT_12436. ERKs are inactivated.
REACT_12599. ERK/MAPK targets.
REACT_1391. ERK1 activation.
REACT_160086. Regulation of actin dynamics for phagocytic cup formation.
REACT_163701. FCERI mediated MAPK activation.
REACT_169168. Senescence-Associated Secretory Phenotype (SASP).
REACT_169325. Oncogene Induced Senescence.
REACT_169436. Oxidative Stress Induced Senescence.
REACT_18334. NCAM signaling for neurite out-growth.
REACT_200780. Regulation of HSF1-mediated heat shock response.
REACT_21326. Activation of the AP-1 family of transcription factors.
REACT_21384. Thrombin signalling through proteinase activated receptors (PARs).
REACT_22272. Signal transduction by L1.
REACT_2232. RNA Polymerase I Promoter Opening.
REACT_25195. Advanced glycosylation endproduct receptor signaling.
REACT_508. Signal attenuation.
REACT_9470. Signaling by FGFR.
SignaLinki P27361.

Miscellaneous databases

EvolutionaryTracei P27361.
GeneWikii MAPK3.
GenomeRNAii 5595.
NextBioi 21714.
PROi P27361.
SOURCEi Search...

Gene expression databases

ArrayExpressi P27361.
Bgeei P27361.
CleanExi HS_MAPK3.
Genevestigatori P27361.

Family and domain databases

InterProi IPR011009. Kinase-like_dom.
IPR003527. MAP_kinase_CS.
IPR008349. MAPK_ERK1/2.
IPR000719. Prot_kinase_dom.
IPR017441. Protein_kinase_ATP_BS.
IPR002290. Ser/Thr_dual-sp_kinase_dom.
IPR008271. Ser/Thr_kinase_AS.
[Graphical view ]
Pfami PF00069. Pkinase. 1 hit.
[Graphical view ]
PRINTSi PR01770. ERK1ERK2MAPK.
SMARTi SM00220. S_TKc. 1 hit.
[Graphical view ]
SUPFAMi SSF56112. SSF56112. 1 hit.
PROSITEi PS01351. MAPK. 1 hit.
PS00107. PROTEIN_KINASE_ATP. 1 hit.
PS50011. PROTEIN_KINASE_DOM. 1 hit.
PS00108. PROTEIN_KINASE_ST. 1 hit.
[Graphical view ]
ProtoNeti Search...

Publicationsi

« Hide 'large scale' publications
  1. "Molecular cloning, expression, and characterization of the human mitogen-activated protein kinase p44erk1."
    Charest D.L., Jirik F., Harder K., Pelech S.L., Mordret G.
    Mol. Cell. Biol. 13:4679-4690(1993) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
    Tissue: Hepatoma.
  2. "Properties of human ERK1b."
    Aebersold D.M., Yung Y., Seger R.
    Submitted (APR-2001) to the EMBL/GenBank/DDBJ databases
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
  3. "Identification of dominant negative Erk1/2 variants in cancer cells."
    Cheng H., Ren S., Qiu R., Wang M., Feng Y.H.
    Submitted (FEB-2006) to the EMBL/GenBank/DDBJ databases
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
  4. SeattleSNPs variation discovery resource
    Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
  5. "The sequence and analysis of duplication-rich human chromosome 16."
    Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.
    , Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J., Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D., Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M., Rubin E.M., Pennacchio L.A.
    Nature 432:988-994(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
  6. Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
  7. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
    Tissue: Lymph.
  8. Bienvenut W.V., Dhillon A.S., Kolch W.
    Submitted (FEB-2008) to UniProtKB
    Cited for: PROTEIN SEQUENCE OF 2-15; 33-41; 88-94; 117-131; 212-220; 279-287; 303-318 AND 360-370, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, IDENTIFICATION BY MASS SPECTROMETRY.
    Tissue: Hepatoma.
  9. "Extracellular signal-regulated kinases in T cells: characterization of human ERK1 and ERK2 cDNAs."
    Owaki H., Makar R., Boulton T.G., Cobb M.H., Geppert T.D.
    Biochem. Biophys. Res. Commun. 182:1416-1422(1992) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 14-379 (ISOFORM 1).
  10. "Heterogeneous expression of four MAP kinase isoforms in human tissues."
    Gonzalez F.A., Raden D.L., Rigby M.R., Davis R.J.
    FEBS Lett. 304:170-178(1992) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 25-379 (ISOFORM 1).
  11. "Serine 25 of oncoprotein 18 is a major cytosolic target for the mitogen-activated protein kinase."
    Marklund U., Brattsand G., Shingler V., Gullberg M.
    J. Biol. Chem. 268:15039-15047(1993) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION IN PHOSPHORYLATION OF STMN1.
  12. "Human immunodeficiency virus type 1 Nef binds directly to LCK and mitogen-activated protein kinase, inhibiting kinase activity."
    Greenway A.L., Azad A., Mills J., McPhee D.A.
    J. Virol. 70:6701-6708(1996) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH HIV-1 NEF.
  13. "MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates."
    Fukunaga R., Hunter T.
    EMBO J. 16:1921-1933(1997) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION IN PHOSPHORYLATION OF MKNK1/MNK1.
  14. "MAPKAPK5, a novel mitogen-activated protein kinase (MAPK)-activated protein kinase, is a substrate of the extracellular-regulated kinase (ERK) and p38 kinase."
    Ni H., Wang X.S., Diener K., Yao Z.
    Biochem. Biophys. Res. Commun. 243:492-496(1998) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION IN PHOSPHORYLATION OF MAPKAPK5.
  15. "Phosphorylation by CK2 and MAPK enhances calnexin association with ribosomes."
    Chevet E., Wong H.N., Gerber D., Cochet C., Fazel A., Cameron P.H., Gushue J.N., Thomas D.Y., Bergeron J.J.
    EMBO J. 18:3655-3666(1999) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION IN PHOSPHORYLATION OF CANX, INTERACTION WITH CANX.
  16. "Extracellular regulated kinases (ERK) 1 and ERK2 are authentic substrates for the dual-specificity protein-tyrosine phosphatase VHR. A novel role in down-regulating the ERK pathway."
    Todd J.L., Tanner K.G., Denu J.M.
    J. Biol. Chem. 274:13271-13280(1999) [PubMed] [Europe PMC] [Abstract]
    Cited for: DEPHOSPHORYLATION BY DUSP3.
  17. "Identification of a cytoplasmic-retention sequence in ERK2."
    Rubinfeld H., Hanoch T., Seger R.
    J. Biol. Chem. 274:30349-30352(1999) [PubMed] [Europe PMC] [Abstract]
    Cited for: SUBCELLULAR LOCATION, INTERACTION WITH MAP2K1/MEK1, DOMAIN.
  18. "Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation."
    Brondello J.M., Pouyssegur J., McKenzie F.R.
    Science 286:2514-2517(1999) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION IN PHOSPHORYLATION OF DUSP1.
  19. "IEX-1: a new ERK substrate involved in both ERK survival activity and ERK activation."
    Garcia J., Ye Y., Arranz V., Letourneux C., Pezeron G., Porteu F.
    EMBO J. 21:5151-5163(2002) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION IN PHOSPHORYLATION OF IER3, INTERACTION WITH IER3, ENZYME REGULATION.
  20. "Insulin receptor substrate 4 associates with the protein IRAS."
    Sano H., Liu S.C.H., Lane W.S., Piletz J.E., Lienhard G.E.
    J. Biol. Chem. 277:19439-19447(2002) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH NISCH.
  21. "Signal transduction via the stem cell factor receptor/c-Kit."
    Ronnstrand L.
    Cell. Mol. Life Sci. 61:2535-2548(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: REVIEW ON ROLE IN KIT SIGNALING.
  22. "Phosphorylation of Grb10 by mitogen-activated protein kinase: identification of Ser150 and Ser476 of human Grb10zeta as major phosphorylation sites."
    Langlais P., Wang C., Dong L.Q., Carroll C.A., Weintraub S.T., Liu F.
    Biochemistry 44:8890-8897(2005) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION IN PHOSPHORYLATION OF GRB10.
  23. "Bidirectional signals transduced by DAPK-ERK interaction promote the apoptotic effect of DAPK."
    Chen C.H., Wang W.J., Kuo J.C., Tsai H.C., Lin J.R., Chang Z.F., Chen R.H.
    EMBO J. 24:294-304(2005) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH DAPK1.
  24. "Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38."
    Ouwens D.M., de Ruiter N.D., van der Zon G.C., Carter A.P., Schouten J., van der Burgt C., Kooistra K., Bos J.L., Maassen J.A., van Dam H.
    EMBO J. 21:3782-3793(2002) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION IN PHOSPHORYLATION OF ATF2.
  25. "EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2."
    Wu Y., Chen Z., Ullrich A.
    Biol. Chem. 384:1215-1226(2003) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION IN PHOSPHORYLATION OF FRS2.
  26. "Phosphorylation of serine 147 of tis21/BTG2/pc3 by p-Erk1/2 induces Pin-1 binding in cytoplasm and cell death."
    Hong J.W., Ryu M.S., Lim I.K.
    J. Biol. Chem. 280:21256-21263(2005) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION IN PHOSPHORYLATION OF BTG2.
  27. "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."
    Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.
    Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract]
    Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Tissue: Cervix carcinoma.
  28. "Association and regulation of heat shock transcription factor 4b with both extracellular signal-regulated kinase mitogen-activated protein kinase and dual-specificity tyrosine phosphatase DUSP26."
    Hu Y., Mivechi N.F.
    Mol. Cell. Biol. 26:3282-3294(2006) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION, INTERACTION WITH HSF4.
  29. "ALK activation induces Shc and FRS2 recruitment: Signaling and phenotypic outcomes in PC12 cells differentiation."
    Degoutin J., Vigny M., Gouzi J.Y.
    FEBS Lett. 581:727-734(2007) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION.
  30. "Mutations of beta-arrestin 2 that limit self-association also interfere with interactions with the beta2-adrenoceptor and the ERK1/2 MAPKs: implications for beta2-adrenoceptor signalling via the ERK1/2 MAPKs."
    Xu T.-R., Baillie G.S., Bhari N., Houslay T.M., Pitt A.M., Adams D.R., Kolch W., Houslay M.D., Milligan G.
    Biochem. J. 413:51-60(2008) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH ARRB2.
  31. "Distinct functions of natural ADAM-15 cytoplasmic domain variants in human mammary carcinoma."
    Zhong J.L., Poghosyan Z., Pennington C.J., Scott X., Handsley M.M., Warn A., Gavrilovic J., Honert K., Kruger A., Span P.N., Sweep F.C., Edwards D.R.
    Mol. Cancer Res. 6:383-394(2008) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH ADAM15.
  32. "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle."
    Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M.
    Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract]
    Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Tissue: Cervix carcinoma.
  33. "Extracellular signal-regulated kinase 2 (ERK2) phosphorylation sites and docking domain on the nuclear pore complex protein Tpr cooperatively regulate ERK2-Tpr interaction."
    Vomastek T., Iwanicki M.P., Burack W.R., Tiwari D., Kumar D., Parsons J.T., Weber M.J., Nandicoori V.K.
    Mol. Cell. Biol. 28:6954-6966(2008) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH TPR.
  34. Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-202 AND TYR-204, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Tissue: Cervix carcinoma.
  35. "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach."
    Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.
    Anal. Chem. 81:4493-4501(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
  36. "The D816V mutation of c-Kit circumvents a requirement for Src family kinases in c-Kit signal transduction."
    Sun J., Pedersen M., Ronnstrand L.
    J. Biol. Chem. 284:11039-11047(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION IN KIT SIGNALING PATHWAY, PHOSPHORYLATION.
  37. "Tumor suppressor density-enhanced phosphatase-1 (DEP-1) inhibits the RAS pathway by direct dephosphorylation of ERK1/2 kinases."
    Sacco F., Tinti M., Palma A., Ferrari E., Nardozza A.P., Hooft van Huijsduijnen R., Takahashi T., Castagnoli L., Cesareni G.
    J. Biol. Chem. 284:22048-22058(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION AT TYR-204, DEPHOSPHORYLATION BY PTPRJ AT TYR-204.
  38. "Protein kinase SGK1 enhances MEK/ERK complex formation through the phosphorylation of ERK2: implication for the positive regulatory role of SGK1 on the ERK function during liver regeneration."
    Won M., Park K.A., Byun H.S., Kim Y.R., Choi B.L., Hong J.H., Park J., Seok J.H., Lee Y.H., Cho C.H., Song I.S., Kim Y.K., Shen H.M., Hur G.M.
    J. Hepatol. 51:67-76(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH SGK1.
  39. Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-198, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
  40. "A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy."
    Lorenz K., Schmitt J.P., Schmitteckert E.M., Lohse M.J.
    Nat. Med. 15:75-83(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION AT THR-207, ENZYME REGULATION, SUBUNIT, SUBCELLULAR LOCATION.
  41. "The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions."
    Yoon S., Seger R.
    Growth Factors 24:21-44(2006) [PubMed] [Europe PMC] [Abstract]
    Cited for: REVIEW ON FUNCTION.
  42. "The ERK signaling cascade--views from different subcellular compartments."
    Yao Z., Seger R.
    BioFactors 35:407-416(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: REVIEW ON FUNCTION, REVIEW ON SUBCELLULAR LOCATION.
  43. "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."
    Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K.
    Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-202 AND TYR-204, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Tissue: Leukemic T-cell.
  44. "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."
    Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.
    Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
    Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Tissue: Cervix carcinoma.
  45. Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
  46. "The ERK cascade: distinct functions within various subcellular organelles."
    Wortzel I., Seger R.
    Genes Cancer 2:195-209(2011) [PubMed] [Europe PMC] [Abstract]
    Cited for: REVIEW ON ENZYME REGULATION, REVIEW ON FUNCTION.
  47. "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation."
    Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.
    Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-202 AND TYR-204, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
  48. "Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features."
    Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T., Giglione C.
    Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012) [PubMed] [Europe PMC] [Abstract]
    Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
  49. Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
  50. Cited for: X-RAY CRYSTALLOGRAPHY (2.39 ANGSTROMS), PHOSPHORYLATION AT TYR-204.
  51. "Patterns of somatic mutation in human cancer genomes."
    Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.
    , Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.
    Nature 446:153-158(2007) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANT [LARGE SCALE ANALYSIS] LYS-323.

Entry informationi

Entry nameiMK03_HUMAN
AccessioniPrimary (citable) accession number: P27361
Secondary accession number(s): A8CZ58, B0LPG3, Q8NHX1
Entry historyi
Integrated into UniProtKB/Swiss-Prot: August 1, 1992
Last sequence update: January 23, 2007
Last modified: September 3, 2014
This is version 169 of the entry and version 4 of the sequence. [Complete history]
Entry statusiReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Miscellaneousi

Keywords - Technical termi

3D-structure, Complete proteome, Direct protein sequencing, Reference proteome

Documents

  1. Human chromosome 16
    Human chromosome 16: entries, gene names and cross-references to MIM
  2. Human entries with polymorphisms or disease mutations
    List of human entries with polymorphisms or disease mutations
  3. Human polymorphisms and disease mutations
    Index of human polymorphisms and disease mutations
  4. MIM cross-references
    Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot
  5. PDB cross-references
    Index of Protein Data Bank (PDB) cross-references
  6. Human and mouse protein kinases
    Human and mouse protein kinases: classification and index
  7. SIMILARITY comments
    Index of protein domains and families

External Data

Dasty 3

Similar proteinsi